ABOUT US Leadership Andrew Hirsch President and Chief Executive Officer Adam Crystal, M.D., Ph.D. Chief Medical Officer Stew Fisher, Ph.D. Chief Scientific Officer Lauren White Chief Financial Officer Jolie Siegel Chief Legal Officer Kelly Schick Chief People Officer Kendra Adams Senior Vice President, Communications and IR Isabel Chiu, Ph.D. Senior Vice President, Strategic Alliances and Program Management Chris Nasveschuk, Ph.D. Senior Vice President, Chemistry Roy Pollock, Ph.D. Senior Vice President, Biological Sciences Mayra Reyes-Armour, Ph.D. Senior Vice President, Technical Operations, Quality and Facilities Board of Directors Marc Cohen Co-Founder, Executive Chairman Andrew Hirsch President, Chief Executive Officer, Director Ken Anderson, M.D. Director Alain Cohen Director Bruce Downey Director Glenn Dubin Director Elena Prokupets Director Malcolm Salter Director Scientific Advisory Board Ken Anderson, M.D. Kraft Family Professor of Medicine, Harvard Medical School Director of the Jerome Lipper Multiple Myeloma Center and Lebow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute Scott Armstrong, M.D., Ph.D. Chairman of the Department of Pediatric Oncology, Dana-Farber Cancer Institute Associate Chief, Department of Hematology/Oncology, Boston Children’s Hospital David G. Nathan Professor of Pediatrics, Harvard Medical School Ryan B. Corcoran, M.D., Ph.D. Director of the Gastrointestinal Cancer Center Program Scientific Director of the Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center Nathanael Gray, Ph.D. Faculty Lead, Medicinal Chemistry Professor, Chemical and Systems Biology, Stanford University Stanford Cancer Institute Director of Cancer Drug Discovery Christopher Kirk, Ph.D. President and Chief Scientific Officer, Kezar Life Sciences (NASDAQ : KZR) Ross Levine, M.D. Attending Physician on the Leukemia Service, Department of Medicine, the Laurence Joseph Dineen Chair in Leukemia Research Professor of Medicine, Weill Cornell Medical College Director of the MSK Center for Hematologic Malignancies Clinical Advisory Board Chris Bowden, M.D. Strategic Advisor and Former Chief Medical Officer, Agios Pharmaceuticals (NASDAQ: AGIO) Beni Wolf, M.D., Ph.D. Chief Medical Officer, Relay Therapeutics (NASDAQ: RLAY) Randi Isaacs, M.D. Chief Medical Officer, Werewolf Therapeutics (NASDAQ: HOWL) Hagop Youssoufian, M.D. Former faculty member at Harvard Medical School and Baylor College of Medicine Former CMO of ImClone-Lilly and other biotechnology companies Member, American Society of Clinical Investigation Phone 617-231-0700 Location 490 Arsenal Way, Suite 200 Watertown, MA 02472 Email info@c4therapeutics.com © 2021 C4 Therapeutics, Inc. Privacy Policy Terms of Use Agreement Sitemap